Loading clinical trials...
Loading clinical trials...
Evaluation of safety and clinical efficacy of an active ingredient versus placebo for the treatment of mild to moderate Atopic Dermatitis (AD) adults.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Greenpharma S.A.S.
Collaborators
NCT07166497 · Mild to Moderate Atopic Dermatitis
NCT06052995 · Mild to Moderate Atopic Dermatitis
NCT05729074 · Mild to Moderate Atopic Dermatitis
NCT01079897 · Mild to Moderate Atopic Dermatitis
Complife Italia S.r.l.
San Martino Siccomario
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions